National Research Centre

Medical Research Ethics Committee

MREC Reviewer Comment

Protocol Title

Evaluation of pyrazole and sulfonamide hybrid for antidiabetic activity

Completely satisfied and informative data

Needs Explanation

Comments to the applicant

1)Please specify the area of expertise of the PI. 2)The tested dose of the new synthesised drug( 5mg/kg(b.wt,) ) must be determined after previous toxicological study for safety.this test is not described in the article. 3)Please complete the precautions that will be followed to minimize health risk for humans and animals when using the toxic agent STZ. 4)More details are required in the Flowchart .

Comment to the Committee

Informed consent form:

N/A

Login

Email Address *
Enter your username or email address
password *
Enter your password

Reset Password

User login/email

Still not a member? Register